Clarivate (NYSE:CLVT) Releases FY 2026 Earnings Guidance

Clarivate (NYSE:CLVT) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.700-0.800 for the period, compared to the consensus estimate of 0.700. The company issued revenue guidance of $2.3 billion-$2.4 billion, compared to the consensus revenue estimate of $2.4 billion.

Clarivate Price Performance

CLVT traded up $0.30 on Wednesday, reaching $2.81. The company had a trading volume of 5,867,172 shares, compared to its average volume of 6,830,417. The company has a fifty day moving average of $2.43 and a 200-day moving average of $2.95. The company has a market capitalization of $1.81 billion, a P/E ratio of -9.32 and a beta of 1.39. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89. Clarivate has a one year low of $1.66 and a one year high of $4.77.

Clarivate (NYSE:CLVT) last announced its earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.04. The firm had revenue of $585.50 million during the quarter, compared to analyst estimates of $568.78 million. Clarivate had a negative net margin of 8.19% and a positive return on equity of 8.30%. Clarivate’s revenue was down 1.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.14 EPS. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, equities research analysts anticipate that Clarivate will post 0.63 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on CLVT shares. The Goldman Sachs Group lowered shares of Clarivate from a “buy” rating to a “neutral” rating and decreased their target price for the company from $4.20 to $3.60 in a research report on Thursday, January 8th. Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a report on Friday, March 27th. Citigroup cut their price target on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating for the company in a report on Wednesday, March 4th. Wall Street Zen downgraded shares of Clarivate from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. Finally, Royal Bank Of Canada cut their price target on shares of Clarivate from $5.00 to $3.00 and set a “sector perform” rating for the company in a report on Wednesday, February 25th. Five equities research analysts have rated the stock with a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average price target of $3.22.

Key Headlines Impacting Clarivate

Here are the key news stories impacting Clarivate this week:

• Positive Sentiment: Q1 beat on EPS and revenue — Clarivate reported $0.18 EPS vs. consensus $0.14 and revenue of $585.5M vs. ~$568.8M expected, a clean beat that underpins the near?term share strength. Clarivate Reports First Quarter 2026 Results
• Positive Sentiment: FY?2026 guidance reaffirmed — Management set EPS guidance of $0.70–$0.80 (in line with consensus) and reiterated revenue targets, which reduced near?term forecast uncertainty and supported the rally. Clarivate Reports First Quarter 2026 Results
• Positive Sentiment: New product: Nexus Connect — Clarivate launched Nexus Connect, an AI gateway for universities that could expand addressable markets in research/education and accelerate SaaS uptake. Product innovation gives investors a visible growth lever. Clarivate Introduces Nexus Connect
• Neutral Sentiment: Management commentary and materials available — The earnings slide deck and call transcript provide more detail on the Value Creation Plan and cash?flow progress; useful for investors assessing execution but not immediately price?moving by itself. Clarivate Plc (CLVT) Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Deleveraging noted — Management highlighted free cash flow generation and debt reduction progress; this supports longer?term financial stability but will take time to materially change multiples. Clarivate Reports First Quarter 2026 Results
• Negative Sentiment: Revenue slipped year?over?year and margins remain negative — Q1 revenue was down ~1.4% YoY and net margin remained negative (-8.2%), keeping profitability concerns front?of?mind for some investors. Clarivate Q1 Results Summary
• Negative Sentiment: Revenue guidance caution — FY revenue guidance sits at the lower end of market expectation (~$2.3B–$2.4B vs. consensus nearer $2.4B), which tempers upside if growth accelerates slower than investors hope. Clarivate Reports First Quarter 2026 Results

Institutional Trading of Clarivate

A number of hedge funds have recently bought and sold shares of CLVT. Jump Financial LLC purchased a new stake in Clarivate during the fourth quarter valued at about $41,000. PharVision Advisers LLC purchased a new stake in Clarivate during the third quarter valued at about $45,000. Pitcairn Co. purchased a new stake in Clarivate during the second quarter valued at about $52,000. RPO LLC purchased a new stake in Clarivate during the fourth quarter valued at about $64,000. Finally, Corsair Capital Management L.P. purchased a new stake in Clarivate during the fourth quarter valued at about $67,000. 85.72% of the stock is owned by hedge funds and other institutional investors.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.